Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980340 · ClinicalTrials.gov registry record
Breath Biomarkers for Sleep Loss and Circadian Timing
A clinical trial, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- 5
- Enrollment target
NCT03980340 is a clinical trial that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 5 participants.
The verdict
NCT03980340 was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Insufficient sleep has both health and safety risks, but currently there are no quick, accurate and inexpensive ways to measure sleep deficiency. The current study aims to use a cutting-edge technology, small molecule analysis (e.g. metabolomics), to detect compounds in breath that reliably change with sleep-wake state and those whose levels vary by time of day.
Interventions
- BEHAVIORAL Short Nap Intervention
- BEHAVIORAL No Nap Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-01-28 |
| Est. Completion | 2025-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03980340
The ClinicalTrials.gov registry entry for NCT03980340 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Short Nap Intervention is the first listed.
NCT03980340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03980340 about?
NCT03980340 is a clinical study titled "Breath Biomarkers for Sleep Loss and Circadian Timing". Insufficient sleep has both health and safety risks, but currently there are no quick, accurate and inexpensive ways to measure sleep deficiency. The current study aims to use a cutting-edge technology, small molecule analysis (e.g. metabolomics), to detect compounds in breath that reliably change w...
What is the current status of trial NCT03980340?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2021-01-28. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT03980340?
The interventions under investigation include: Short Nap Intervention (BEHAVIORAL), No Nap Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03980340?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.